These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1541 related articles for article (PubMed ID: 29655187)

  • 1. Classifying medical histories in US Medicare beneficiaries using fixed vs all-available look-back approaches.
    Conover MM; Stürmer T; Poole C; Glynn RJ; Simpson RJ; Pate V; Jonsson Funk M
    Pharmacoepidemiol Drug Saf; 2018 Jul; 27(7):771-780. PubMed ID: 29655187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of prevalent statin use among older adults identified as statin initiators based on Medicare claims data.
    Young JC; Stürmer T; Lund JL; Funk MJ
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):836-43. PubMed ID: 26991151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restriction of Pharmacoepidemiologic Cohorts to Initiators of Medications in Unrelated Preventive Drug Classes to Reduce Confounding by Frailty in Older Adults.
    Zhang HT; McGrath LJ; Ellis AR; Wyss R; Lund JL; Stürmer T
    Am J Epidemiol; 2019 Jul; 188(7):1371-1382. PubMed ID: 30927359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling confounding of treatment effects in administrative data in the presence of time-varying baseline confounders.
    Gilbertson DT; Bradbury BD; Wetmore JB; Weinhandl ED; Monda KL; Liu J; Brookhart MA; Gustafson SK; Roberts T; Collins AJ; Rothman KJ
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25(3):269-77. PubMed ID: 26608680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical Expenditures Among Medicare Beneficiaries with Statin-Associated Adverse Effects Following Myocardial Infarction.
    Colantonio LD; Deng L; Chen L; Farkouh ME; Monda KL; Harrison DJ; Maya JF; Kilgore ML; Muntner P; Rosenson RS
    Cardiovasc Drugs Ther; 2018 Dec; 32(6):601-610. PubMed ID: 30446883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of expanding the look-back period to all available data in the assessment of covariates.
    Nakasian SS; Rassen JA; Franklin JM
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):890-899. PubMed ID: 28397352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin Discontinuation, Reinitiation, and Persistence Patterns Among Medicare Beneficiaries After Myocardial Infarction: A Cohort Study.
    Booth JN; Colantonio LD; Chen L; Rosenson RS; Monda KL; Safford MM; Kilgore ML; Brown TM; Taylor B; Dent R; Muntner P; Levitan EB
    Circ Cardiovasc Qual Outcomes; 2017 Oct; 10(10):. PubMed ID: 29021332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying bias reduction with fixed-duration versus all-available covariate assessment periods.
    Connolly JG; Schneeweiss S; Glynn RJ; Gagne JJ
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):665-670. PubMed ID: 30786103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs.
    Jung K; McBean AM; Kim JA
    J Manag Care Pharm; 2012 Mar; 18(2):106-15. PubMed ID: 22380470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misclassification of incident hospitalized and outpatient heart failure in administrative claims data: the Atherosclerosis Risk in Communities (ARIC) study.
    Camplain R; Kucharska-Newton A; Cuthbertson CC; Wright JD; Alonso A; Heiss G
    Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):421-428. PubMed ID: 28120359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Algorithms to Identify Statin Intolerance in Medicare Administrative Claim Data.
    Colantonio LD; Kent ST; Huang L; Chen L; Monda KL; Serban MC; Manthripragada A; Kilgore ML; Rosenson RS; Muntner P
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):525-533. PubMed ID: 27389413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study.
    Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS
    Curr Med Res Opin; 2008 Jul; 24(7):1987-2000. PubMed ID: 18554430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of an intervention to increase statin use in medicare members who qualified for a medication therapy management program.
    Stockl KM; Tjioe D; Gong S; Stroup J; Harada AS; Lew HC
    J Manag Care Pharm; 2008; 14(6):532-40. PubMed ID: 18693777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction.
    Serban MC; Colantonio LD; Manthripragada AD; Monda KL; Bittner VA; Banach M; Chen L; Huang L; Dent R; Kent ST; Muntner P; Rosenson RS
    J Am Coll Cardiol; 2017 Mar; 69(11):1386-1395. PubMed ID: 28302290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease.
    Rosenson RS; Kent ST; Brown TM; Farkouh ME; Levitan EB; Yun H; Sharma P; Safford MM; Kilgore M; Muntner P; Bittner V
    J Am Coll Cardiol; 2015 Jan; 65(3):270-7. PubMed ID: 25614424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The price of bouncing back: one-year mortality and payments for acute stroke patients with 30-day bounce-backs.
    Kind AJ; Smith MA; Liou JI; Pandhi N; Frytak JR; Finch MD
    J Am Geriatr Soc; 2008 Jun; 56(6):999-1005. PubMed ID: 18422948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration.
    Patrick AR; Schneeweiss S; Brookhart MA; Glynn RJ; Rothman KJ; Avorn J; Stürmer T
    Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):551-9. PubMed ID: 21394812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between statin adherence level, health care costs, and utilization.
    Zhao Y; Zabriski S; Bertram C
    J Manag Care Spec Pharm; 2014 Jul; 20(7):703-13. PubMed ID: 24967523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Medicare cost-sharing elimination for Cancer screening on utilization.
    Xu WY; Wickizer TM; Jung JK
    BMC Health Serv Res; 2019 Jun; 19(1):392. PubMed ID: 31208422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 78.